Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

7.25
Delayed Data
As of Feb 12
 +0.51 / +7.57%
Today’s Change
6.25
Today|||52-Week Range
32.82
-53.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
AssetsCash28.0M122.2M81.6M66.8M
 
 
 
 
 
Short Term Investment Cash-4.5M94.2M-40.6M-14.8M
 
 
 
 
 
Cash & Short Term Investments201.0M358.5M334.0M303.4M
 
 
 
 
 
 
ReceivablesReceivables427.0K2.0M434.0K1.7M
 
 
 
 
 
 
InventoriesInventories------0.00--
 
Current AssetsOther Current Assets3.5M3.7M5.1M4.1M
 
 
 
 
 
Current Assets205.0M364.1M339.5M309.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross24.8M11.2M11.7M11.9M
 
 
 
 
 
Depreciation-14.2M------
 
 
Intangible Assets30.8M30.5M30.3M30.0M
 
 
 
 
 
Other Assets32.5M32.3M31.9M31.5M
 
 
 
 
 
Total Assets248.0M407.7M383.2M352.6M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.6M3.1M2.0M1.2M
 
 
 
 
 
Accrued Expenses15.0M15.4M21.9M19.6M
 
 
 
 
 
Other Current Liabilities17.6M18.1M24.7M22.4M
 
 
 
 
 
Other Liabilities24.5M21.1M26.7M23.6M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities11.9M11.0M10.6M10.4M
 
 
 
 
 
Total Liabilities36.4M32.1M37.3M34.0M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity211.7M375.6M345.9M318.6M
 
 
 
 
 
Total Shareholder Equity211.7M375.6M345.9M318.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding89.6M98.5M98.5M98.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.